Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.450
+0.030 (2.11%)
Apr 28, 2026, 11:53 AM EDT - Market open
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $49.85 million as of April 28, 2026. Its market cap has decreased by -36.79% in one year.
Market Cap
49.85M
Enterprise Value
42.01M
1-Year Change
-36.79%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $49.85M, a decrease of -75.95%. That is a compound annual growth rate of -47.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 48.82M | 6.77% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 50.62M |
| PDS Biotechnology | 50.26M |
| Atossa Therapeutics | 49.08M |
| Nutriband | 48.57M |
| Xilio Therapeutics | 48.05M |
| Hyperion DeFi | 47.50M |
| Rein Therapeutics | 46.54M |
| Mereo BioPharma Group | 46.29M |